BSAC Spring Conference 2021

Stewarding the AMR agenda through the lenses of prevention, diagnosis and treatment
- Held 29-30 April 2021 - REGISTER NOW to access the recorded conference

This conference is CPD accredited and the content is now open access.


Renascience® is a UK based pharmaceutical company that aims to meet clinical need through the revival of forgotten critical medicines.


We have an experienced management team with proven success acquired across the global pharmaceutical industry and the NHS. We are committed to launching a portfolio of medicines that will provide access and clinical options to physicians and patients.


The critical need for antibiotics has inspired Renascience® to launch Renapime® (Cefepime), the UK’s FIRST and ONLY approved 4th Generation Cephalosporin. Renapime® is licensed for a broad range of indications for Adults and Paediatrics. Find out more at


‘Revive Science, Restore Health’ is the ethos at Renascience® enabling us to bridge the antibiotic discovery void.